Toward a Personalized Approach to Parkinson's Cell Therapy

Todd M Herrington^{1

2}, Jeffrey Schweitzer^{3

4}, Claire Henchcliffe⁵, Bob S Carter^{3

4}, Kwang-Soo Kim^{6

7}

Affiliations

¹ Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
² Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
³ Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
⁴ Department of Neurosurgery, Harvard Medical School, Boston, Massachusetts, USA.
⁵ Department of Neurology, Weill Cornell Medical College, New York, New York, USA.
⁶ Department of Psychiatry, McLean Hospital, Belmont, Massachusetts, USA.
⁷ Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.

PMID: 33463754
DOI: 10.1002/mds.28328

Comment

Toward a Personalized Approach to Parkinson's Cell Therapy

Todd M Herrington et al. Mov Disord. 2020 Nov.

. 2020 Nov;35(11):2119-2120.

doi: 10.1002/mds.28328.

Authors

Todd M Herrington^{1

2}, Jeffrey Schweitzer^{3

4}, Claire Henchcliffe⁵, Bob S Carter^{3

4}, Kwang-Soo Kim^{6

7}

Affiliations

¹ Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
² Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
³ Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
⁴ Department of Neurosurgery, Harvard Medical School, Boston, Massachusetts, USA.
⁵ Department of Neurology, Weill Cornell Medical College, New York, New York, USA.
⁶ Department of Psychiatry, McLean Hospital, Belmont, Massachusetts, USA.
⁷ Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.

PMID: 33463754
DOI: 10.1002/mds.28328

No abstract available

PubMed Disclaimer

Comment in

Reply to: "Toward a Personalized Approach to Parkinson's Cell Therapy".
Kordower JH, Okun MS, Jankovic J. Kordower JH, et al. Mov Disord. 2020 Nov;35(11):2120-2121. doi: 10.1002/mds.28329. Mov Disord. 2020. PMID: 33463751 No abstract available.

Comment on

Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease.
Schweitzer JS, Song B, Herrington TM, Park TY, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q, Henchcliffe C, Kaplitt M, Neff C, Rapalino O, Seo H, Lee IH, Kim J, Kim T, Petsko GA, Ritz J, Cohen BM, Kong SW, Leblanc P, Carter BS, Kim KS. Schweitzer JS, et al. N Engl J Med. 2020 May 14;382(20):1926-1932. doi: 10.1056/NEJMoa1915872. N Engl J Med. 2020. PMID: 32402162 Free PMC article.
Stem Cells: Scientific and Ethical Quandaries of a Personalized Approach to Parkinson's Disease.
Jankovic J, Okun MS, Kordower JH. Jankovic J, et al. Mov Disord. 2020 Aug;35(8):1312-1314. doi: 10.1002/mds.28187. Epub 2020 Jul 7. Mov Disord. 2020. PMID: 32529662 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

K23 NS099380/NS/NINDS NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Toward a Personalized Approach to Parkinson's Cell Therapy

Affiliations

Toward a Personalized Approach to Parkinson's Cell Therapy

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical